A Clinical Study to Evaluate the Safety and Efficacy of the Test Product in Providing Various Skin Benefits.
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 发起方
- 入组人数
- 30
- 试验地点
- 1
- 主要终点
- Evaluation of efficacy of test product in reducing signs of ageing.
研究概览
简要总结
This is a study to evaluate the safety and efficacy of a test product to provide various skin benefits utilizing a full-face single arm study design. Duration of testing [length of time]: 56 days. The study will include a variety of dermatological assessments, instrumental assessments, and self assessments from subjects. Study objectives: improvements in signs of the aging face, overall skin tone, dark spot reduction, skin elasticity and testing of the safety and tolerability of the test product.
研究设计
- 研究类型
- Interventional
- 分配方式
- Not Applicable
- 盲法
- Not Applicable
入排标准
- 年龄范围
- 20.00 Year(s) 至 65.00 Year(s)（—）
- 性别
- Female
入选标准
- •Female subjects in general good health.
- •Female subjects in the age group 20 to 65 years.
- •Female subjects with all skin types, with 50% of subjects having sensitive skin.
- •Female subjects with visible skin concerns such as dark spots, wrinkles, and uneven skin tone.
- •5.10 female subjects with sensitive eyes who regularly wear contact lenses.
- •6.Female subjects who are regular users of makeup.
排除标准
- •Subjects with known skin conditions that may impact the assessment.
- •Subjects with any other signs of significant local irritation or skin disease.
- •Subjects undergoing treatment of any skin condition on their face.
- •Subject having active skin diseases.
- •Subjects who have undergone facial treatments in past 4 weeks.
结局指标
主要结局
Evaluation of efficacy of test product in reducing signs of ageing.
时间窗: Baseline, Day 28, Day 56.
Assessment of the test products effectiveness in improving overall skin tone.
时间窗: Baseline, Day 28, Day 56.
Evaluation of efficacy of the test product for reduction in dark spots.
时间窗: Baseline, Day 28, Day 56.
Reduction in signs of ageing using Antera assessment.
时间窗: Baseline, Day 28, Day 56.
Reduction in dark spot intensity using Spectrophotometer.
时间窗: Baseline, Day 28, Day 56.
Evaluation of improvement in skin elasticity using Cutometer.
时间窗: Baseline, Day 28, Day 56.
次要结局
- 1. Evaluation of Safety and tolerability of the test product through dermatological and ophthalmological assessments.(2. Assessment of prevention of dark spots through subject self assessment.)